BALYASNY ASSET MANAGEMENT L.P. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Leap Therapeutics, Inc. (LPTX)

Filing Manager
BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager
Balyasny Asset Management L.P.
Security
Leap Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
LPTX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 06:22 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 0% 0 0 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self